Lian Brian
Insider CIK 1614578 · SEEL Director · VKTX President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-07-29 | 2026-07-29 | 148,517 | $33.32 | $4.95M | 2,572,441 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-07-29 | 2026-07-29 | 148,517 | $33.32 | $4.95M | 2,572,441 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-07-28 | 2026-07-29 | 221,667 | — | $0 | 2,720,958 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-07-28 | 2026-07-29 | 221,667 | — | $0 | 2,720,958 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 132,454 | $32.29 | $4.28M | 2,600,246 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 41,276 | $34.22 | $1.41M | 2,505,691 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 53,279 | $33.38 | $1.78M | 2,546,967 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 6,400 | $35.07 | $224.4K | 2,499,291 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 176,300 | — | $0 | 176,300 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 78,400 | — | $0 | 2,508,620 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 224,080 | — | $0 | 2,732,700 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 38,989 | $35.01 | $1.37M | 2,419,109 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-10-27 | 2025-10-28 | 70,084 | — | $0 | 2,458,098 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-07-03 | 2025-07-03 | 26,889 | $27.80 | $747.5K | 2,388,014 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-07-02 | 2025-07-03 | 48,333 | — | $0 | 2,414,903 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-01-06 | 2025-01-06 | 175,490 | $42.68 | $7.49M | 2,385,570 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-01-06 | 2025-01-06 | 19,000 | $43.32 | $823.1K | 2,366,570 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2025-01-03 | 2025-01-06 | 78,300 | — | $0 | 78,300 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-01-03 | 2025-01-06 | 163,333 | — | $0 | 2,561,060 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-01-03 | 2025-01-06 | 92,800 | — | $0 | 2,397,727 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-09-20 | 2024-09-20 | 166,130 | — | $0 | 65,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-09-20 | 2024-09-20 | 96,056 | $70.43 | $6.77M | 2,425,001 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-09-20 | 2024-09-20 | 166,130 | $7.77 | $1.29M | 2,521,057 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-09-20 | 2024-09-20 | 200 | $71.99 | $14.4K | 2,304,927 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-09-20 | 2024-09-20 | 119,874 | $71.15 | $8.53M | 2,305,127 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-08-21 | 2024-08-22 | 1,000 | — | $0 | 231,130 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-08-21 | 2024-08-22 | 1,000 | $7.77 | $7.8K | 2,355,927 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-21 | 2024-08-22 | 1,000 | $69.90 | $69.9K | 2,354,927 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-08-19 | 2024-08-19 | 112,870 | — | $0 | 232,130 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-19 | 11,296 | $67.12 | $758.2K | 2,354,927 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-08-19 | 2024-08-19 | 112,870 | $7.77 | $877.0K | 2,467,797 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-19 | 70,132 | $65.33 | $4.58M | 2,397,665 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-19 | 31,442 | $66.37 | $2.09M | 2,366,223 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-07-30 | 2024-07-31 | 30,417 | $58.78 | $1.79M | 2,354,927 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-07-30 | 2024-07-31 | 19,501 | $57.81 | $1.13M | 2,385,344 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-07-30 | 2024-07-31 | 65,941 | $56.95 | $3.76M | 2,404,845 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-07-29 | 2024-07-31 | 163,333 | — | $0 | 2,470,786 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-07-29 | 2024-07-31 | 41,000 | — | $0 | 2,307,453 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-03-27 | 2024-03-27 | 153,948 | $83.34 | $12.83M | 2,266,453 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-03-27 | 2024-03-27 | 221,667 | — | $0 | 2,420,401 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-03-01 | 2024-03-04 | 221,667 | — | $0 | 2,361,549 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-04 | 162,815 | $85.22 | $13.88M | 2,198,734 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-02-09 | 2024-02-09 | 45,000 | $29.90 | $1.35M | 2,139,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-02-08 | 2024-02-08 | 140,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-02-08 | 2024-02-08 | 34,931 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-02-08 | 2024-02-08 | 14,148 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-02-08 | 2024-02-08 | 49,079 | $25.75 | $1.26M | 2,264,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-02-08 | 2024-02-08 | 49,079 | $1.23 | $60.4K | 2,313,961 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-02-08 | 2024-02-08 | 140,000 | $4.65 | $651.0K | 2,404,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-02-08 | 2024-02-08 | 60,000 | $25.95 | $1.56M | 2,344,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-02-08 | 2024-02-08 | 80,000 | $26.95 | $2.16M | 2,264,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-02-08 | 2024-02-08 | 40,000 | $27.45 | $1.10M | 2,224,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-02-08 | 2024-02-08 | 40,000 | $28.90 | $1.16M | 2,184,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-01-31 | 2024-01-31 | 85,000 | — | $0 | 14,148 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-01-31 | 2024-01-31 | 85,000 | $1.23 | $104.5K | 2,349,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-01-31 | 2024-01-31 | 45,000 | $24.95 | $1.12M | 2,264,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-01-31 | 2024-01-31 | 40,000 | $24.45 | $978.0K | 2,309,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-01-30 | 2024-01-30 | 35,000 | — | $0 | 99,148 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-01-30 | 2024-01-30 | 35,000 | $23.95 | $838.3K | 2,264,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-01-30 | 2024-01-30 | 35,000 | $1.23 | $43.0K | 2,299,882 | SEC↗ |
| SEEL SEELOS THERAPEUTICS, INC. | A Award deriv | 2024-01-04 | 2024-01-08 | 1,666 | — | $0 | 1,666 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-01-04 | 2024-01-04 | 39,552 | $18.58 | $734.9K | 2,264,882 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2024-01-03 | 2024-01-04 | 360,000 | — | $0 | 360,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-01-03 | 2024-01-04 | 106,115 | $17.40 | $1.85M | 2,304,434 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-01-03 | 2024-01-04 | 160,000 | — | $0 | 2,410,549 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-01-03 | 2024-01-04 | 108,525 | $17.40 | $1.89M | 2,250,549 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-01-03 | 2024-01-04 | 150,000 | — | $0 | 2,359,074 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-05-01 | 2023-05-01 | 45,000 | $22.45 | $1.01M | 2,197,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-04-19 | 2023-04-21 | 35,000 | $21.45 | $750.8K | 2,242,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-17 | 2023-04-18 | 125,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-17 | 2023-04-18 | 125,000 | $2.15 | $268.8K | 2,432,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-04-17 | 2023-04-18 | 155,000 | $20.45 | $3.17M | 2,277,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-13 | 2023-04-13 | 54,336 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-13 | 2023-04-13 | 54,336 | $1.88 | $102.2K | 2,387,299 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-04-13 | 2023-04-13 | 79,336 | $18.45 | $1.46M | 2,307,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2023-04-03 | 2023-04-03 | 200,000 | $17.57 | $3.51M | 2,332,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2023-04-03 | 2023-04-03 | 300,000 | — | $0 | 2,532,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-04-03 | 2023-04-03 | 22,000 | $17.85 | $392.7K | 2,232,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-31 | 2023-04-03 | 67,970 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-03-31 | 2023-04-03 | 67,970 | $17.45 | $1.19M | 2,254,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-31 | 2023-04-03 | 67,970 | $9.49 | $645.0K | 2,322,933 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-30 | 2023-04-03 | 115,852 | — | $0 | 134,148 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-30 | 2023-04-03 | 19,530 | — | $0 | 67,970 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-03-30 | 2023-04-03 | 65,382 | $17.45 | $1.14M | 2,254,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-03-30 | 2023-04-03 | 88,000 | $16.95 | $1.49M | 2,320,345 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-30 | 2023-04-03 | 19,530 | $9.49 | $185.3K | 2,408,345 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-30 | 2023-04-03 | 115,852 | $1.23 | $142.5K | 2,388,815 | SEC↗ |
| SEEL SEELOS THERAPEUTICS, INC. | A Award deriv | 2023-01-05 | 2023-01-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2023-01-04 | 2023-01-04 | 28,619 | $8.42 | $241.0K | 2,272,963 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-04 | 600,000 | — | $0 | 600,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2023-01-03 | 2023-01-04 | 68,252 | $8.52 | $581.5K | 2,301,582 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2023-01-03 | 2023-01-04 | 266,667 | — | $0 | 2,369,834 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2022-12-30 | 2023-01-04 | 66,127 | $9.40 | $621.6K | 2,103,167 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2022-12-30 | 2023-01-04 | 121,667 | — | $0 | 2,169,294 | SEC↗ |
| SEEL SEELOS THERAPEUTICS, INC. | A Award deriv | 2022-01-05 | 2022-01-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2022-01-04 | 2022-01-05 | 26,432 | $4.62 | $122.1K | 2,036,686 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 390,000 | — | $0 | 390,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2022-01-03 | 2022-01-05 | 173,333 | — | $0 | 2,063,118 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2022-01-03 | 2022-01-05 | 36,319 | $4.88 | $177.2K | 1,889,785 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-09-28 | 2021-09-30 | 55,500 | — | $0 | 1,952,557 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-09-28 | 2021-09-30 | 27,750 | $6.50 | $180.4K | 1,924,807 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-01-19 | 2021-01-19 | 5,611 | $6.68 | $37.5K | 1,894,181 | SEC↗ |
| SEEL SEELOS THERAPEUTICS, INC. | A Award deriv | 2021-01-06 | 2021-01-08 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 369,000 | — | $0 | 369,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-01-04 | 2021-01-06 | 16,973 | $5.80 | $98.4K | 1,899,792 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-01-04 | 2021-01-06 | 164,000 | — | $0 | 1,876,432 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-01-04 | 2021-01-06 | 40,333 | — | $0 | 1,916,765 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-01-03 | 2021-01-06 | 31,545 | $5.63 | $177.6K | 1,712,432 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2020-09-15 | 2020-09-16 | 55,500 | — | $0 | 1,761,555 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2020-09-15 | 2020-09-16 | 19,192 | $6.25 | $120.0K | 1,742,363 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2020-01-19 | 2020-01-21 | 3,195 | $7.18 | $22.9K | 1,704,312 | SEC↗ |
| SEEL SEELOS THERAPEUTICS, INC. | A Award deriv | 2020-01-06 | 2020-01-07 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2020-01-03 | 2020-01-03 | 345,000 | — | $0 | 345,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2020-01-03 | 2020-01-03 | 153,333 | — | $0 | 1,714,289 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2020-01-03 | 2020-01-03 | 6,782 | $7.77 | $52.7K | 1,707,507 | SEC↗ |
| SEEL SEELOS THERAPEUTICS, INC. | A Award deriv | 2019-03-20 | 2019-03-21 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SEEL SEELOS THERAPEUTICS, INC. | A Award deriv | 2019-03-20 | 2019-03-21 | 24,000 | — | $0 | 24,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2019-01-19 | 2019-01-22 | 4,333 | $8.78 | $38.0K | 1,560,152 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2019-01-03 | 2019-01-03 | 235,554 | — | $0 | 235,554 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2019-01-03 | 2019-01-03 | 80,897 | — | $0 | 1,564,485 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2018-05-04 | 2018-05-08 | 10,086 | $4.22 | $42.6K | 1,483,012 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2018-01-19 | 2018-01-23 | 140,000 | — | $0 | 140,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2018-01-19 | 2018-01-23 | 40,000 | — | $0 | 1,493,098 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2017-01-05 | 2017-01-05 | 34,931 | — | $0 | 34,931 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2017-01-05 | 2017-01-05 | 250,000 | — | $0 | 250,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2016-03-14 | 2016-03-15 | 54,336 | — | $0 | 54,336 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2016-03-04 | 2016-03-08 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | C Conversion deriv | 2015-05-04 | 2015-05-06 | 0 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 87,500 | — | $0 | 87,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | C Conversion deriv | 2015-05-04 | 2015-05-06 | 0 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | C Conversion | 2015-05-04 | 2015-05-06 | 2,731 | — | $0 | 1,426,825 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | C Conversion | 2015-05-04 | 2015-05-06 | 9,927 | — | $0 | 1,436,752 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2015-05-04 | 2015-05-06 | 16,346 | $9.49 | $155.1K | 1,453,098 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2015-05-04 | 2015-05-06 | 87,500 | — | $0 | 1,424,094 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | D To issuer | 2015-05-04 | 2015-05-06 | 2,313,406 | — | $0 | 1,336,594 | SEC↗ |